People · Operator

Briggs Duncan Morrison

Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology

1
Companies
4
Filings
$81.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Auron Therapeutics, Inc.BiotechnologySeries B$81.8M$159.4M2022
Operator network

Briggs Duncan Morrison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alexandra Cantley · 8 companies · 1 sharedAlexandra CantleyIsaac Ciechanover · 5 companies · 1 sharedIsaac CiechanoverAlon Duncan Lazarus · 1 companies · 1 sharedAlon Duncan Lazar…Anna Duncan French · 1 companies · 1 sharedAnna Duncan FrenchChristopher Duncan Guiffre · 1 companies · 1 sharedChristopher Dunca…Eric Duncan Shiozaki · 1 companies · 1 sharedEric Duncan Shioz…John Duncan Higgons · 1 companies · 1 sharedJohn Duncan Higgo…Katharine Yen · 1 companies · 1 sharedKatharine YenPini Duncan Orbach · 1 companies · 1 sharedPini Duncan OrbachSerge Duncan Messerlian · 1 companies · 1 sharedSerge Duncan Mess…Victoria Duncan Richon · 1 companies · 1 sharedVictoria Duncan R…Auron Therapeutics, Inc. · $81.8M raisedAuron Therapeutics, I…Briggs Duncan MorrisonBM
Briggs Duncan Morrison Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Briggs Duncan Morrison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Alexandra Cantley18
Isaac Ciechanover15
Katharine Yen11
Victoria Duncan Richon11
Anna Duncan French11
Serge Duncan Messerlian11
Alon Duncan Lazarus11
Christopher Duncan Guiffre11
Eric Duncan Shiozaki11
John Duncan Higgons11
Pini Duncan Orbach11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.